Date de publication: 1 août 2014
Promoteur – Intermédiaire Financier
GRUPO FERRER INTERNACIONAL SALieu
Description
The project concerns financing of research and development (R&D) activities in a number of well-defined therapeutic areas.
Objectifs
The project covers the promoter’s research activities in the fields of central nervous system affections, infections and inflammatory diseases, oncology, diagnostics, and development in cardiovascular, respiratory and other therapeutical areas.
Secteur(s)
Montant BEI envisagé (montant approximatif)
EUR 50 million
Coût total (montant approximatif)
EUR 116 million
Aspects environnementaux
The project mainly concerns investments in R&D that are expected to be carried out in existing facilities already authorised for the same purpose and would therefore not require an Environmental Impact Assessment (EIA) under the Directive 2011/92/EU. Full environmental details will be verified during the appraisal.
Passation des marchés
The promoter is a private company not operating in the Utilities sector and not having the status of a contracting authority. Thus it is not covered by EU Directives on procurement. However, the promoter’s procurement procedures are expected to be in line with EIB guidelines for private sector projects. The Bank’s services will verify details during the projects' due diligence.
Statut
Signé - 7/05/2015